MetLife Investment Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-55,977
Closed -$1.17M 2876
2022
Q3
$1.17M Hold
55,977
0.01% 1113
2022
Q2
$1.16M Hold
55,977
0.01% 1137
2022
Q1
$940K Buy
55,977
+19,202
+52% +$336K 0.01% 1375
2021
Q4
$734K Hold
36,775
0.01% 1283
2021
Q3
$667K Hold
36,775
0.01% 1363
2021
Q2
$993K Sell
36,775
-5,749
-14% -$161K 0.01% 1165
2021
Q1
$1.27M Sell
42,524
-3,886
-8% -$133K 0.01% 1034
2020
Q4
$1.33M Buy
46,410
+3,005
+7% +$81.1K 0.01% 999
2020
Q3
$1.06M Hold
43,405
0.01% 1000
2020
Q2
$777K Buy
+43,405
New +$571K 0.01% 1138
2019
Q4
Sell
-56,663
Closed -$674K 2347
2019
Q3
$674K Sell
56,663
-249
-0.4% -$4.61K 0.01% 1265
2019
Q2
$1.39M Sell
56,912
-1,331
-2% -$38.3K 0.01% 968
2019
Q1
$1.86M Buy
+58,243
New +$2.07M 0.02% 847

Other funds holding CVET

MetLife Investment Management's CVET Position: Q4 2022 in Review

MetLife Investment Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 55,977 shares — an estimated $1.17M sold.

MetLife Investment Management first reported a position in CVET in Q1 2019 and held it in 13 quarters. The position peaked at $1.86M in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • MetLife Investment Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 55,977 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $1.17M.
  • MetLife Investment Management first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • MetLife Investment Management's Covetrus, Inc. Common Stock position peaked at $1.86M in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.